Halozyme Therapeutics, Inc. (HALO) SEC filings
HALO SEC filings moved a median of +0.03% by the close. HALO SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the HALO overview →
62 measured HALO SEC filing events.
Where these HALO SEC filings landedvs 61 measured HALO SEC filing reactions
| Middle 50% of HALO SEC filing reactions | -1.74% to +2.03% |
|---|---|
| Median reaction (to close) | +0.03% |
| Measured reactions | 61 |
Point-in-time · zero look-ahead
Half of the 61 HALO SEC filing events with a measured close landed between -1.74% and +2.03%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K HALOZYME THERAPEUTICS, For: Sep 28 | SEC filing · Form 8-K | +0.09% | -2.72% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Sep 22 | SEC filing · Form 8-K | +0.42% | -2.66% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Sep 17 | SEC filing · Form 8-K | +1.39% | +2.49% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Sep 16 | SEC filing · Form 8-K | +0.80% | +2.43% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Aug 14 | SEC filing · Form 8-K | -0.17% | +1.16% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | +2.33% | +13.32% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Aug 06 | SEC filing · Form 8-K | +2.33% | +13.32% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Jun 30 | SEC filing · Form 8-K | -0.83% | +2.03% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | -1.57% | +0.20% | |
| Form 8-K HALOZYME THERAPEUTICS, For: May 11 | SEC filing · Form 8-K | -1.57% | +0.20% | |
| Form 8-K HALOZYME THERAPEUTICS, For: May 05 | SEC filing · Form 8-K | +0.20% | -2.02% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Apr 30 | SEC filing · Form 8-K | +1.09% | +0.71% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Apr 22 | SEC filing · Form 8-K | +0.05% | -1.39% | |
| Form ARS HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | -0.10% | -0.56% | |
| Form DEF 14A HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form DEF | -0.10% | -0.56% | |
| Form DEFA14A HALOZYME THERAPEUTICS, | SEC filing · Form DEFA14A | -0.10% | -0.56% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Mar 12 | SEC filing · Form 8-K | -0.04% | -2.78% | |
| Form 10-K HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -2.44% | -6.15% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Feb 17 | SEC filing · Form 8-K | -2.44% | -6.15% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Jan 28 | SEC filing · Form 8-K | +1.71% | +2.65% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Dec 04 | SEC filing · Form 8-K | +0.08% | +0.89% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Dec 04 | SEC filing · Form 8-K | +1.18% | -0.96% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Nov 18 | SEC filing · Form 8-K | -0.69% | -1.79% | |
| Form S-8 HALOZYME THERAPEUTICS, | SEC filing · Form S-8 | -0.99% | -0.40% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Nov 06 | SEC filing · Form 8-K | +0.46% | — | |
| Form 8-K HALOZYME THERAPEUTICS, For: Nov 06 | SEC filing · Form 8-K | +0.24% | -1.74% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Nov 05 | SEC filing · Form 8-K | +0.83% | +0.13% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -3.13% | +0.07% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Nov 03 | SEC filing · Form 8-K | -3.13% | +0.07% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Oct 14 | SEC filing · Form 8-K | +0.89% | +2.35% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Oct 01 | SEC filing · Form 8-K | -1.18% | -0.87% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Sep 30 | SEC filing · Form 8-K | -0.39% | -2.35% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Sep 30 | SEC filing · Form 8-K | -0.44% | -0.90% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -1.45% | -1.81% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Aug 05 | SEC filing · Form 8-K | -1.45% | -1.81% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +0.03% | +10.13% | |
| Form 8-K HALOZYME THERAPEUTICS, For: May 06 | SEC filing · Form 8-K | +0.03% | +10.13% | |
| Form 8-K HALOZYME THERAPEUTICS, For: May 01 | SEC filing · Form 8-K | +0.45% | +0.03% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Mar 17 | SEC filing · Form 8-K | -0.99% | -2.30% | |
| Form ARS HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | +0.12% | +2.73% | |
| Form DEF 14A HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form DEF | +0.12% | +2.73% | |
| Form DEFA14A HALOZYME THERAPEUTICS, | SEC filing · Form DEFA14A | +0.12% | +2.73% | |
| Form 10-K HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -3.03% | -2.08% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Feb 18 | SEC filing · Form 8-K | -3.03% | -2.08% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Feb 11 | SEC filing · Form 8-K | -0.38% | -1.40% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Jan 08 | SEC filing · Form 8-K | -0.98% | -0.67% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | -3.40% | +2.69% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Oct 31 | SEC filing · Form 8-K | -3.40% | +2.69% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Jun 30 | SEC filing · Form 10-Q | -3.71% | -3.36% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Aug 06 | SEC filing · Form 8-K | -3.71% | -3.36% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Mar 31 | SEC filing · Form 10-Q | +1.61% | +0.14% | |
| Form 8-K HALOZYME THERAPEUTICS, For: May 07 | SEC filing · Form 8-K | +1.61% | +0.14% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Apr 25 | SEC filing · Form 8-K | +0.09% | +0.03% | |
| Form ARS HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form ARS | -0.15% | -1.37% | |
| Form DEF 14A HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form DEF | -0.15% | -1.37% | |
| Form DEFA14A HALOZYME THERAPEUTICS, | SEC filing · Form DEFA14A | -0.15% | -1.37% | |
| Form PRE 14A HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form PRE | +0.22% | +1.22% | |
| Form 10-K HALOZYME THERAPEUTICS, For: Dec 31 | SEC filing · Form 10-K | -0.15% | +1.70% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Feb 20 | SEC filing · Form 8-K | -0.15% | +1.70% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Jan 17 | SEC filing · Form 8-K | -2.31% | +0.25% | |
| Form 10-Q HALOZYME THERAPEUTICS, For: Sep 30 | SEC filing · Form 10-Q | +0.76% | +5.84% | |
| Form 8-K HALOZYME THERAPEUTICS, For: Nov 06 | SEC filing · Form 8-K | +0.76% | +5.84% |
Keep exploring
More HALO: earnings → · analyst actions → · HALO overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Autolus Therapeutics plc - American Depositary Shares (AUTL) | 377 | -0.00% | 45% |
| Solid Biosciences Inc. (SLDB) | 375 | -0.17% | 46% |
| RITTER PHARMACEUTICALS (RTTR) | 374 | -0.61% | 37% |
| MIRAGEN THERAPEUTICS INC (MGEN) | 369 | -0.39% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.